Abstract
A novel series of 2,4,6-trisubstituted 1,3,5-triazine derivatives bearing aryl hydrazone moiety were designed and synthesized under the guidance of scaffold hopping and bioisosterism from the autophagy inhibitor VLX600. The target compounds were evaluated for cytotoxicity against HT-29 by MTT assay with VLX600 as positive control. Then, ten potent target compounds (5c-5f, 5i-5r, 5s, 5t) were further evaluated against two cancer cell lines H460 and A549 and one normal cell line WI-38. Most of them exhibited significant cytotoxicity against one or more cell lines. Particularly, a promising compound 5f was identified, which exhibited the most potent cytotoxicity against HT-29, H460 and A549 cancer cell lines with IC50 values of 0.047 M, 0.071 M and 0.071 M, respectively, which was 10- to 62-folds more potent than VLX600 (IC50 = 0.47 M, 4.1 M, 4.4 M). The preliminary structure-activity relationships (SARs) of the compounds were also discussed.
Keywords: 2, 4, 6-trisubstituted 1, 3, 5-triazine, VLX600, cytotoxicity, synthesis, SAR.
Medicinal Chemistry
Title:Design, Synthesis, and Cytotoxicity of Novel 2,4,6-Trisubstituted 1,3,5- triazines Bearing Aryl Hydrazone Moiety as Potent Antitumor Agent
Volume: 12 Issue: 7
Author(s): Limei Wang, Sijia Zhao, Guanglong Bao, Yu Zhang, Shuancheng Xi, Guolin Zhou, Xin Zhai and Ping Gong
Affiliation:
Keywords: 2, 4, 6-trisubstituted 1, 3, 5-triazine, VLX600, cytotoxicity, synthesis, SAR.
Abstract: A novel series of 2,4,6-trisubstituted 1,3,5-triazine derivatives bearing aryl hydrazone moiety were designed and synthesized under the guidance of scaffold hopping and bioisosterism from the autophagy inhibitor VLX600. The target compounds were evaluated for cytotoxicity against HT-29 by MTT assay with VLX600 as positive control. Then, ten potent target compounds (5c-5f, 5i-5r, 5s, 5t) were further evaluated against two cancer cell lines H460 and A549 and one normal cell line WI-38. Most of them exhibited significant cytotoxicity against one or more cell lines. Particularly, a promising compound 5f was identified, which exhibited the most potent cytotoxicity against HT-29, H460 and A549 cancer cell lines with IC50 values of 0.047 M, 0.071 M and 0.071 M, respectively, which was 10- to 62-folds more potent than VLX600 (IC50 = 0.47 M, 4.1 M, 4.4 M). The preliminary structure-activity relationships (SARs) of the compounds were also discussed.
Export Options
About this article
Cite this article as:
Wang Limei, Zhao Sijia, Bao Guanglong, Zhang Yu, Xi Shuancheng, Zhou Guolin, Zhai Xin and Gong Ping, Design, Synthesis, and Cytotoxicity of Novel 2,4,6-Trisubstituted 1,3,5- triazines Bearing Aryl Hydrazone Moiety as Potent Antitumor Agent, Medicinal Chemistry 2016; 12 (7) . https://dx.doi.org/10.2174/1573406412666160106154551
DOI https://dx.doi.org/10.2174/1573406412666160106154551 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
Call for Papers in Thematic Issues
Carbohydrates in Computational and Medicinal Chemistry
Carbohydrates are the most essential organic molecules and are involved in the maintenance of various physiological and metabolic processes in living organisms. Carbohydrate-based compounds have come to the attention of researchers because of their significant contributions to biological functions, such as cell development and cell proliferation, connections between several cells, ...read more
Recent Advances in the Medicinal Chemistry of Cancer
Scope of the Thematic Issue: Correlation between structure and function is one of the important aspects of the success of anti-cancer compounds associated with their structure-activity interactions, physiology, biochemical, molecular, and genetic processes. Overcoming these obstacles is key to obtaining further insights into developments in rational drug design, bioorganic chemistry, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Heterocyclic Moieties as HDAC Inhibitors: Role in Cancer Therapeutics
Mini-Reviews in Medicinal Chemistry The Docking Based 3D-QSAR Studies on Isoindolinone Derived Inhibitors of p53-MDM2 Binding
Letters in Drug Design & Discovery Virtual Screening of the Flavonoids Compounds with the SARS-CoV-2 3C-like Protease as the Lead Compounds for the COVID-19
Coronaviruses Oxidative Stress and Neurodegenerative Diseases: Looking for a Therapeutic Solution Inspired on Benzopyran Chemistry
Current Topics in Medicinal Chemistry The Challenges Involved in Modeling Toxicity Data In Silico: A Review
Current Pharmaceutical Design Plant-Derived Natural Compounds for the Treatment of Amyotrophic Lateral Sclerosis: An Update
Current Neuropharmacology Desferrioxamine as Immunomodulatory Agent During Microorganism Infection
Current Pharmaceutical Design Endocrine Disruptors and Obesity: An Overview
Endocrine, Metabolic & Immune Disorders - Drug Targets Palladacycles as Antimicrobial Agents
Current Medicinal Chemistry Synthetic Attempts Towards Eminent Anti-viral Candidates of SARS-CoV
Mini-Reviews in Medicinal Chemistry Design of New Improved Curcumin Derivatives to Multi-targets of Cancer and Inflammation
Current Drug Targets Recent Advances in the Synthesis of Optically Active Compounds Bearing a Chiral Heteroatom Center in the Group 13-16 Elements
Current Organic Chemistry Improving the Stability of Aptamers by Chemical Modification
Current Medicinal Chemistry Synthesis and Preliminary Biological Activity of Some New Pyrazole Derivatives as Acyclonucleoside Analogues
Letters in Drug Design & Discovery Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitors for New Anti-Diabetic Agent
Current Topics in Medicinal Chemistry Community-Acquired Pneumonia in Children
Recent Patents on Inflammation & Allergy Drug Discovery Erythema Pernio-Like in Four Adolescents in the Era of the Coronavirus-2 Infection
Reviews on Recent Clinical Trials Progress in the Preclinical Discovery and Clinical Development of Class I and Dual Class I/IV Phosphoinositide 3-Kinase (PI3K) Inhibitors
Current Medicinal Chemistry Binaphthyl-Derived Mono-, Bi- and Multi-Functional Lewis and Brønsted Base Organocatalysts: A New Vista for Asymmetric Synthesis
Current Organic Chemistry Diagnostic Value of Assessment of Serum Cortisol, Hepcidin and Thyroid Hormones Levels in Neonates with Late-Onset Sepsis
Infectious Disorders - Drug Targets